Review
Copyright ©The Author(s) 2019.
World J Gastroenterol. Sep 14, 2019; 25(34): 5049-5068
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5049
Table 1 A brief summary of the biological significance of some common tumor-associated autoantibodies
Representative tumor-associated autoantigensAuthors, yearTumor typeBiological significance
p53Chapman et al[11], 2012LungEarly detection
Takeda et al[14], 2001ColorectalIncreased recurrence
Anderson et al[15], 2010OvarianIncreased survival
NY-ESO-1Shan et al[16], 2013LungEarly detection
Fosså et al[17], 2004ProstateDecreased survival
Elke et al[18], 1999MelanomaTherapeutic monitoring
MUC1Pedersen et al[19], 2014OvarianEarly detection
Kurtenkov et al[20], 2007GastricIncreased survival
HuChapman et al[11], 2011LungEarly detection
Graus et al[21], 1997LungTherapeutic monitoring and increased survival